GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) » Definitions » Gross-Profit-to-Asset %

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Gross-Profit-to-Asset % : 41.09% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Zhuzhou Qianjin Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Zhuzhou Qianjin Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Dec. 2023 was ¥1,884 Mil. Zhuzhou Qianjin Pharmaceutical Co's average Total Assets over the quarter that ended in Dec. 2023 was ¥4,584 Mil. Therefore, Zhuzhou Qianjin Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 41.09%.


Zhuzhou Qianjin Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhuzhou Qianjin Pharmaceutical Co Gross-Profit-to-Asset % Chart

Zhuzhou Qianjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.95 39.39 39.07 39.94 37.63

Zhuzhou Qianjin Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.47 37.12 39.23 37.92 41.09

Competitive Comparison of Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset % falls into.



Zhuzhou Qianjin Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Zhuzhou Qianjin Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1751.756/( (4634.628+4676.882)/ 2 )
=1751.756/4655.755
=37.63 %

Zhuzhou Qianjin Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1883.624/( (4490.339+4676.882)/ 2 )
=1883.624/4583.6105
=41.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Zhuzhou Qianjin Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Zhuzhou Qianjin Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Jinshangou Road, Hetang District, Zhuzhou, Hunan, CHN, 412003
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules.

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Headlines

No Headlines